<div><div><h2>Q2 results: Aurobindo Pharma profit falls nearly 22% to Rs611 crore</h2></div><div>aurobindo pharma ltd india s second-largest drugmaker by market capitalisation posted a 21.7% fall in its second-quarter profit on monday hurt by higher expenses but beat analysts  estimates. net profit was rs611 crore ($83.81 million) in the quarter ended 30 september compared with rs781 crore a year earlier the company said. analysts on average had expected a profit of rs606 crore according to ibes data from refinitiv. total expenses rose 14.3% to rs3964 crore while income from operations climbed 7.19% to rs4667 crore.</div></div>